O{double acute}rszemnyirokcsomó-biopszia neoadjuváns kemoterápiát igénylo{double acute} emlo{double acute}rákoknál

Translated title of the contribution: Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer

Zoltán Mátrai, László Tóth, Csaba Polgár, István Láng, Mária Godény, István Sinkovics, Zsolt Horváth, Mária Bidlek, Nóra Udvarhelyi, Alexandra Bartal, Ákos Sávolt, Mihály Újhelyi, Miklós Kásler

Research output: Contribution to journalArticle

1 Citation (Scopus)


The indication of neoadjuvant chemotherapy has been recently extended; it is now applied not only in locally advanced breast cancer but in primarily resecable tumours as well, in order to promote breast conservation. Based on recent clinical results, the reconsideration of traditional lymph node dissection in axillary staging is timely in patients receiving neoadjuvant chemotherapy. Precise axillary staging needs surgical removal of lymph nodes. Based on prospective randomised trials, sentinel lymph node biopsy appears to be appropriate for axillary staging even in tumours requiring neoadjuvant treatment. The extended indication of sentinel lymph node biopsy raises several questions and problems. In the present paper the authors review the results and possible limitations of sentinel lymph node biopsy in relation to neoadjuvant chemotherapy.

Original languageHungarian
Pages (from-to)73-84
Number of pages12
JournalMagyar onkologia
Issue number2
Publication statusPublished - 2011


ASJC Scopus subject areas

  • Medicine(all)

Cite this